Literature DB >> 9775220

The dystrophic retina in multisystem disorders: the electroretinogram in neuronal ceroid lipofuscinoses.

R G Weleber1.   

Abstract

The neuronal ceroid lipofuscinoses (NCL) are neurodegenerative disorders with psychomotor deterioration, seizures, visual failure and premature death, all associated with abnormal storage of lipoproteins within lysosomes. The most common forms of NCL are an infantile form (INCL, CLN1), a late infantile form (LINCL, CLN2) and a juvenile onset form (JNCL, CLN3). The electroretinogram (ERG) is abnormal early in all three of these forms and eventually is totally ablated. The purpose of this report is to describe the ERG in INCL, LINCL and JNCL. The ERGs of 7 patients who were examined by the author over the past 15 years were reviewed. Ganzfeld ERG responses were recorded using the ISCEV standard protocol and an intensity response series over a 3.7 log unit range. The earliest ERG manifestation of INCL is a marked loss of the scotopic and photopic b-wave with relative preservation of the a-wave; this defect, which was evident for both rods and cones, suggests preservation of photoreceptor outer segment function with severe disturbance of transmission of the signal to the second-order neuron, the bipolar cells. For LINCL, the rod responses were mildly abnormal but more preserved than in INCL or JNCL. The cone b-wave amplitudes in patients with early LINCL were severely subnormal with prolonged implicit times. Patients with JNCL invariably showed severe to profound ERG abnormalities when first tested, with essentially no rod-mediated activity and marked loss of a-wave amplitudes with even greater loss of b-wave amplitudes, creating electronegative configuration waveforms. Differences in the ERG responses were thus found that provide further clues to the earliest site of pathology within the retina.

Entities:  

Mesh:

Year:  1998        PMID: 9775220     DOI: 10.1038/eye.1998.148

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  31 in total

1.  Juvenile neuronal ceroid lipofuscinosis.

Authors:  S Gulati; R Maheshwari; M Kabra; I C Verma; V Kalra
Journal:  Indian J Pediatr       Date:  2000-09       Impact factor: 1.967

2.  Homogeneous polymerase chain reaction nucleobase quenching assay to detect the 1-kbp deletion in CLN3 that causes Batten disease.

Authors:  Paul G Rothberg; Denia Ramirez-Montealegre; Sharon D Frazier; David A Pearce
Journal:  J Mol Diagn       Date:  2004-08       Impact factor: 5.568

3.  Batten disease: features to facilitate early diagnosis.

Authors:  J Collins; G E Holder; H Herbert; G G W Adams
Journal:  Br J Ophthalmol       Date:  2006-06-05       Impact factor: 4.638

4.  A novel deletion variant in CLN3 with highly variable expressivity is responsible for juvenile neuronal ceroid lipofuscinoses.

Authors:  Naser Gilani; Ehsan Razmara; Mehmet Ozaslan; Ihsan Kareem Abdulzahra; Saeid Arzhang; Ali Reza Tavasoli; Masoud Garshasbi
Journal:  Acta Neurol Belg       Date:  2021-03-30       Impact factor: 2.396

5.  When ethics constrains clinical research: trial design of control arms in "greater than minimal risk" pediatric trials.

Authors:  Inmaculada de Melo-Martín; Dolan Sondhi; Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2011-05-19       Impact factor: 5.695

6.  Gene Therapy Targeting the Inner Retina Rescues the Retinal Phenotype in a Mouse Model of CLN3 Batten Disease.

Authors:  Sophia-Martha Kleine Holthaus; Mikel Aristorena; Ryea Maswood; Olha Semenyuk; Justin Hoke; Aura Hare; Alexander J Smith; Sara E Mole; Robin R Ali
Journal:  Hum Gene Ther       Date:  2020-07       Impact factor: 5.695

7.  Oral cysteamine bitartrate and N-acetylcysteine for patients with infantile neuronal ceroid lipofuscinosis: a pilot study.

Authors:  Sondra W Levin; Eva H Baker; Wadih M Zein; Zhongjian Zhang; Zenaide M N Quezado; Ning Miao; Andrea Gropman; Kurt J Griffin; Simona Bianconi; Goutam Chandra; Omar I Khan; Rafael C Caruso; Aiyi Liu; Anil B Mukherjee
Journal:  Lancet Neurol       Date:  2014-07-02       Impact factor: 44.182

Review 8.  Vision loss in juvenile neuronal ceroid lipofuscinosis (CLN3 disease).

Authors:  Madhu M Ouseph; Mark E Kleinman; Qing Jun Wang
Journal:  Ann N Y Acad Sci       Date:  2016-01-08       Impact factor: 5.691

Review 9.  Juvenile neuronal ceroid lipofuscinosis (JNCL) and the eye.

Authors:  Sara Bozorg; Denia Ramirez-Montealegre; Mina Chung; David A Pearce
Journal:  Surv Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 6.048

10.  Phenotypic characterization of a mouse model of juvenile neuronal ceroid lipofuscinosis.

Authors:  Martin L Katz; Gary S Johnson; Gregory E Tullis; Bo Lei
Journal:  Neurobiol Dis       Date:  2007-09-07       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.